GlaxoSmithKline Pharmaceuticals on Monday said its consolidated net profit declined 72% to ₹46 crore for the December quarter.
The drug firm had reported a net profit of ₹165 crore in the year-ago period.
Total income increased to ₹833 crore for the third quarter of the current fiscal as compared with ₹826 crore in the year-ago period, GlaxoSmithKline Pharmaceuticals said in a statement.
Read more on economictimes.indiatimes.com
(You can now subscribe to our Economic Times WhatsApp channel)